<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01160900</url>
  </required_header>
  <id_info>
    <org_study_id>Sperimental Registry nÂ°844</org_study_id>
    <nct_id>NCT01160900</nct_id>
  </id_info>
  <brief_title>FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization.</brief_title>
  <acronym>FIT</acronym>
  <official_title>Phase III Study, Multivessel Percutaneous Treatment During Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera San Camillo Forlanini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera San Camillo Forlanini</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Few reports described outcomes of complete compared with infarct related artery (IRA) only
      revascularization in patients with ST elevation myocardial infarction (STEMI) and multivessel
      coronary disease (CAD).

      The purpose of this study is to determine outcome (death, myocardial infarction, target
      vessel failure) of 180 consecutive patients with STEMI and multivessel CAD undergoing primary
      angioplasty.

      Before the first angioplasty patients are randomized to 2 different strategies: 1) culprit
      vessel angioplasty only, 2) staged revascularization.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death at 30 days</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>stent thrombosis</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>target vessel failure</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>re-acute myocardial infarction</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>bleeding</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>timi frame count</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vascular site access complications</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Ischemia</condition>
  <condition>Heart Failure</condition>
  <condition>Necrosis</condition>
  <condition>Stents</condition>
  <arm_group>
    <arm_group_label>multivessel revascularization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Complete Revascularization : the Infarcted related artery was opened followed by dilatation of other significantly narrowed arteries during the same procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angioplasty all lesions</intervention_name>
    <description>treatment by coronary angioplasty and drug eluting stent of all lesions, adjunctive use of prasugrel and bivalirudin</description>
    <arm_group_label>multivessel revascularization</arm_group_label>
    <other_name>drug eluting stent, prasugrel, bivalirudin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  myocardial acute infarction

          -  prolonged chest pain (&gt;20 minute) started less &lt;12 hours before arrive in hospital

          -  ST segment elevation of &gt;1mm in &gt;2 contiguous leads

          -  new left bundle branch block

          -  diameter of the coronary suitable of angioplasty &gt;2mm

          -  the patients agrees to the study protocol and provides a written consensus

          -  two or more coronary suitable for angioplasty

        Exclusion Criteria:

          -  refused written consensus

          -  hypersensitivity or contraindication to any of the following medications: heparin
             bivalirudin aspirin prasugrel stainless steel

          -  history of bleeding

          -  cardiogenic shock (PA &lt; 90mmHg)

          -  chronic total occlusion in the second lesion

          -  TIMI Flow &lt; II in the culprit lesion

          -  recent pregnancy

          -  history of intra-cerebral major hemorrhagic stroke

          -  an elective surgical procedure is planned that would necessitate interruption of
             thienopyridines during the first six months post enrollment life expectancy &lt;1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Camillo Forlanini</name>
      <address>
        <city>Roma</city>
        <zip>00151</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2010</study_first_submitted>
  <study_first_submitted_qc>July 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2010</study_first_posted>
  <last_update_submitted>July 12, 2010</last_update_submitted>
  <last_update_submitted_qc>July 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Interventional Cardiology, A O San Camillo Forlanini Rome</name_title>
    <organization>Marco Stefano Nazzaro</organization>
  </responsible_party>
  <keyword>cardiovascular diseases</keyword>
  <keyword>heart disease</keyword>
  <keyword>hemorrhage</keyword>
  <keyword>coronary angioplasty</keyword>
  <keyword>drug eluting stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prasugrel Hydrochloride</mesh_term>
    <mesh_term>Bivalirudin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

